Tevogen Bio
€0
0
+€0+0% Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
3JunExpected
Expected EPS
-1.73278
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-26.25MNet Income
Analyst Ratings
$0.00Average Price Target
The highest estimate is 0.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 0%
Hold 100%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow G280.F. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.
Show more...
CEO
Dr. Ryan H. Saadi M.D., M.P.H, M.P.H.
Employees
18
Country
US
ISIN
US88165K2006
WKN
000A4230Y
Listings
0 Comments
Share your thoughts
FAQ
What is Tevogen Bio stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Tevogen Bio stocks are traded under the ticker G280.F.
When is the next Tevogen Bio earnings date?▼
Tevogen Bio is going to release the next earnings report on June 03, 2026.
What were Tevogen Bio earnings last quarter?▼
G280.F earnings for the last quarter are -1.27 EUR per share, whereas the estimation was -1.27 EUR resulting in a +0% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Tevogen Bio revenue for the last year?▼
Tevogen Bio revenue for the last year amounts to 0 EUR.
What is Tevogen Bio net income for the last year?▼
G280.F net income for the last year is -26.25M EUR.
How many employees does Tevogen Bio have?▼
As of April 03, 2026, the company has 18 employees.
In which sector is Tevogen Bio located?▼
Tevogen Bio operates in the Health Care sector.
When did Tevogen Bio complete a stock split?▼
The last stock split for Tevogen Bio was on March 06, 2026 with a ratio of 1:50.
Where is Tevogen Bio headquartered?▼
Tevogen Bio is headquartered in Warren, US.